Company intelligence / Profile preview

Xiuwu Pharmaceutical Group

Changchun or Tonghua (HQ), Jilin, Chinacnverify.com ↗

Ownership: Private
Development stage: Other

Overview

Xiuzheng Pharmaceutical Group is one of China’s largest private pharmaceutical enterprises, with extensive operations spanning R&D, production, marketing of patent medicines, chemical drugs, biologics, Chinese traditional medicine products, healthcare products, diagnostic reagents/equipment, and medicinal material cultivation. By 2016 it had assets of $2.53 billion USD and annual revenue approaching $10 billion USD. It ranked No. 53 among China's Top 500 Private Enterprises that year.

Modalities: Small moleculeBiologic
Industry: Pharma

Beyond the preview

Go deeper on Xiuwu Pharmaceutical Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiuwu Pharmaceutical Group.

Explore the full profile